These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 383623)

  • 41. Opportunistic gram-negative bacillary infections in leukemia. Oral manifestations during myelosuppression.
    Dreizen S; Bodey GP; Brown LR
    Postgrad Med; 1974 Apr; 55(4):133-9. PubMed ID: 4594534
    [No Abstract]   [Full Text] [Related]  

  • 42. Bacteremic shock due to gram-negative bacilli. Some concepts of pathogenesis and management based on recent developments.
    McHenry MC
    Geriatrics; 1969 Apr; 24(4):101-11. PubMed ID: 4304532
    [No Abstract]   [Full Text] [Related]  

  • 43. [The antimicrobial activity of sisomicin against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M
    Jpn J Antibiot; 1987 Nov; 40(11):1895-905. PubMed ID: 3327965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacokinetic investigations on sisomicin in children (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter J
    Monatsschr Kinderheilkd (1902); 1978 Aug; 126(8):512-7. PubMed ID: 683201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cephalexin monohydrate in the treatment of bone and soft tissue infections].
    Hernandez B; Bravo PA; Zarraga J; Fernandez A; Cruz Cruz M; Añorve I; Martinez J
    Prensa Med Mex; 1970; ():32-5. PubMed ID: 4931113
    [No Abstract]   [Full Text] [Related]  

  • 46. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
    Dzierzanowska D; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of sisomicin and gentamicin in the treatment of serious systemic infections.
    Leal del Rosal P; Leal del Rosal L; Riosvelasco Carrasco AG; Aguirre Rascon E
    Curr Med Res Opin; 1980; 6(10):663-9. PubMed ID: 7428404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of gram-negative bacillary meningitis in adults.
    Rahal JJ
    Ann Intern Med; 1972 Aug; 77(2):295-302. PubMed ID: 4345082
    [No Abstract]   [Full Text] [Related]  

  • 49. [Septrin in the treatment of chronic pyelonephritis and certain other bacterial infections. Immediate effect of treatment after short-term administration of the drug].
    Droszcz W; Gietko G
    Pol Arch Med Wewn; 1970 Jun; 44(6):653-7. PubMed ID: 4915612
    [No Abstract]   [Full Text] [Related]  

  • 50. Sisomicin: an aminoglycoside antibiotic that is highly effective against Pseudomonas.
    Sanders WE; Sanders CC
    J Int Med Res; 1981; 9(3):168-76. PubMed ID: 6786934
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies.
    Mazzei T; Paradiso M; Nicoletti I; Periti P
    J Infect Dis; 1976 Nov; 134 SUPPL():S374-9. PubMed ID: 993629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
    Strausbaugh LJ; Mandaleris CD; Sande MA
    J Lab Clin Med; 1977 Apr; 89(4):692-701. PubMed ID: 321713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sisomicin: a review of eight years' experience.
    Sanders WE; Sanders CC
    Rev Infect Dis; 1980; 2(2):182-95. PubMed ID: 6994206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Basic and clinical examinations of CS-1170 in pediatrics (author's transl)].
    Nanri S; Sunakawa K; Hara N; Yamashita N; Akita H; Hotta M; Izeki M; Morikawa Y; Osano M; Ichihashi Y
    Jpn J Antibiot; 1979 Jan; 32(1):18-24. PubMed ID: 370423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gentamicin in the treatment of severe, hospital-acquired gram-negative infections.
    Young LS; Louria DB; Armstrong D
    Trans N Y Acad Sci; 1967 Mar; 29(5):579-88. PubMed ID: 4864706
    [No Abstract]   [Full Text] [Related]  

  • 57. [Bacteriological studies on fosfomycin. Antibacterial activity in vitro and in vivo (author's transl)].
    Miyauchi K; Yoshida T; Kasai T; Saito T; Hirano H
    Jpn J Antibiot; 1975 Jun; 28(3):320-30. PubMed ID: 807758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical and bacteriological evaluation of sisomicin in sixteen cases of severe bronchopulmonary infection (author's transl)].
    Duwoos H; Carpentier P; Nouveau J; Guyonnaud CD; Abderhalden C
    Sem Hop; 1979 Nov 8-15; 55(37-38):1713-22. PubMed ID: 230590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Netilmicin in moderate to severe infections in newborns and infants: a study of efficacy, tolerance and pharmacokinetics.
    Henriksson P; Svenningsen NW; Juhlin I; Haeger K
    Scand J Infect Dis Suppl; 1980; Suppl 23():155-9. PubMed ID: 7010546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A survey of 99 surgical patients treated with gentamycin.
    Lindahl F; Bagerskov A
    Acta Chir Scand; 1973; 139(4):368-71. PubMed ID: 4198011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.